Bennicas & Associates’s Omega Healthcare OHI Stock Holding History

Bennicas & Associates’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,222	Closed	-$226K	–	101
2020 Q4	$226K	Buy	+6,222	New	+$211K	0.13%	91
2020 Q1	–	Sell	-6,350	Closed	-$269K	–	84
2019 Q4	$269K	Sell	6,350 -200	-3%	-$8.46K	0.19%	75
2019 Q3	$274K	Sell	6,550 -200	-3%	-$7.79K	0.21%	71
2019 Q2	$248K	Sell	6,750 -100	-1%	-$3.65K	0.21%	71
2019 Q1	$261K	Hold	6,850	–	–	0.23%	69
2018 Q4	$241K	Hold	6,850	–	–	0.22%	76
2018 Q3	$224K	Hold	6,850	–	–	0.19%	83
2018 Q2	$212K	Buy	+6,850	New	+$196K	0.19%	82
2017 Q4	–	Sell	-7,800	Closed	-$249K	–	89
2017 Q3	$249K	Hold	7,800	–	–	0.21%	80
2017 Q2	$258K	Hold	7,800	–	–	0.23%	76
2017 Q1	$257K	Hold	7,800	–	–	0.23%	77
2016 Q4	$244K	Buy	+7,800	New	+$241K	0.22%	78

Other funds holding OHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bennicas & Associates's OHI Position: Q1 2021 in Review

Bennicas & Associates sold out of Omega Healthcare (OHI) in Q1 2021, closing a stake of 6,222 shares — an estimated $226K sold.

Bennicas & Associates first reported a position in OHI in Q4 2016 and held it in 12 quarters. The position peaked at $274K in Q3 2019. 522 funds tracked by Wall St. Rank hold OHI as of Q1 2021.

Bennicas & Associates reported no remaining Omega Healthcare position as of Q1 2021 after selling out during the quarter.
Bennicas & Associates sold 6,222 Omega Healthcare shares in Q1 2021, an estimated $226K.
Bennicas & Associates first reported a position in Omega Healthcare in Q4 2016 and held it in 12 quarters.
Bennicas & Associates's Omega Healthcare position peaked at $274K in Q3 2019.
522 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2021.

Based on Bennicas & Associates's 13F filing for Q1 2021, filed 15 Apr 2021.